Science Committee

The Science Committee evaluates new scientific evidence about COPD care, and prepares updates to scientific reports on COPD diagnosis, management, and prevention.

 

Claus Vogelmeier, MD, Chair

University of Marburg

Marburg, Germany

Alvar Agusti, MD

Respiratory Institute, Hospital
Clinic, IDIBAPS
Univ. Barcelona and Ciberes

Barcelona, Spain

Antonio Anzueto, MD

South Texas Veterans Health Care System
University of Texas, Health

San Antonio, Texas, USA

Jean Bourbeau, MD

McGill University Health Centre Montreal
McGill University

Montreal, Canada

Gerard Criner, MD

Temple University School of Medicine

Philadelphia, Pennsylvania, USA

David Halpin, MD

University of Exeter Medical School
College of Medicine and Health
University of Exeter, Exeter

Devon, UK

MeiLan K. Han, MD MS

University of Michigan

Ann Arbor, Michigan, USA

Fernando Martinez, MD MS

New York-Presbyterian Hospital/Weill Cornell Medical Center

New York, New York, USA

Maria Montes de Oca, MD

Hospital Universitario de Caracas
Universidad Central de Venezuela
Centro Médico de Caracas

Caracas, Venezuela

Obianuju Ozoh, MBBS, FMCP, MSc, ATSF

College of Medicine, University of Lagos

Lagos, Nigeria

Alberto Papi, MD

University of Ferrara

Ferrara, Italy

Ian Pavord, MA DM

Respiratory Medicine Unit and Oxford
Respiratory NIHR Biomedical Research
Centre, Nuffield Department of Medicine
University of Oxford

Oxford, UK

Nicolas Roche, MD

Pneumologie, Hôpital Chochin,
AP-HP.Centre - Université de Paris
UMR 1016
Institut Chochin

Paris, France

Don D. Sin, MD

St Paul's Hospital
University of British Columbia

Vancouver, Canada

Dave Singh, MD

University of Manchester

Manchester, UK

Robert Stockley, MD DSc

University Hospital

Birmingham, UK

Thierry Troosters

Research Group for Rehabilitation in Internal Disorders
Laboratory of Respiratory Diseases and Thoracic Surgery (BREATHE)

Leuven, Belgiu

Jadwiga A. Wedzicha, MD

National Heart & Lung Institute
Imperial College London

London, UK

GOLD Committee members disclose relationships (personal benefits, shares, and non-personal interests) with profit-making organizations in December of each year using the following definitions:

View Board and Science Committee Disclosures